3.2 Semaglutide and fecal microbiota transplantation improved abnormal weight gain, body fat, blood lipid levels, fasting blood glucose, and insulin levels in obese mice, improving insulin resistance and impaired insulin sensitivity. The gene discussed is INS; the disease is Insulin resistance.